September 26, 2013

Press Release No. 1

News about Aarti Drugs Limited

The media had reports that FDA issues warning letter to Aarti Drugs.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

Aarti Drugs Limited has vide its letter inter-alia stated,"We confirm that our USFDA site at Tarapur had been inspected in Oct'2012. Subsequently, we submitted response to USFDA by Nov-Dec'12. Recently, we have received a warning letter from USFDA pertaining to few of our responses which need to be further corrected. For this we have already submitted an initial response to USFDA. In addition to that, we have already hired a USA based FDA consultant to further review our responses and send another detailed response by 15th Oct' 2013. We are putting efforts to further enhance the quality systems to avoid such things in further. Aarti Drugs continues to cooperate with FDA to resolve the issues at the earliest."